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In vitro digestion studies often use animal digestive enzyme extracts as substitutes of human gastric and
pancreatic secretions. Pancreatin from porcine origin is thus commonly used to provide relevant pancreatic
enzymes such as proteases, amylase and lipase. Rabbit gastric extracts (RGE) have been recently introduced to
provide gastric lipase in addition to pepsin. Before preparing simulated gastric and pancreatic extracts with
targeted enzyme activities as described in in vitro digestion protocols, it is important to determine the activities of
enzyme preparations using validated methods. The purpose of this inter-laboratory study within the INFOGEST
network was to test the repeatability and reproducibility of lipase assays using the pH-stat technique for
measuring the activities of gastric and pancreatic lipases from various sources. Twenty-one laboratories having
different pH-stat devices received the same protocol with identical batches of RGE and two pancreatin sources.
Lipase assays were performed using tributyrin as a substrate and three different amounts (50, 100 and 200 µg) of
each enzyme preparation. The repeatability results within individual laboratories were satisfactory with co
efficients of variation (CVs) ranging from 4 to 8% regardless of the enzyme amount tested. However, the interlaboratory variability was high (CV > 15%) compared to existing standards for bioanalytical assays. We iden
tified and weighted the contributions to inter-laboratory variability of several parameters associated with the
various pH-stat equipment used in this study (e.g. reaction vessel volume and shape, stirring mode and rate,
burette volume for the automated delivery of sodium hydroxide). Based on this, we established recommendations
for improving the reproducibility of lipase assays using the pH-stat technique. Defining accurate and complete
recommendations on how to correctly quantify activity levels of enzyme preparations is a gateway to promising
comparison of in vitro data obtained from different laboratories following the same in vitro digestion protocol.

1. Introduction

Rivière, & Verger, 2000). In some assays with fluorescent or UVabsorbing (Beisson et al., 1999; Serveau-Avesque, Verger, Rodriguez,
& Abousalham, 2013; Ulker et al., 2016), TAG substrates have been
developed to allow high throughput assays using microtiter plates. They
are adapted for studying purified enzymes but have not been validated
with complex samples of digestion mixtures. Therefore, lipase assays
using TAG emulsions are still the most specific and sensitive option.
Sensitivity is due firstly to the high specific activities of lipases on
emulsified TAG (several hundred to thousand international units (U) per
mg of pure enzyme; 1 U = 1 µmole of fatty acid (FA) release per minute)
and secondly, to the acid-base titration of the reaction products, i.e. FA,
that can be performed using the pH-stat technique (Beisson et al., 2000).
Various types of oils with short, medium and long chain FAs or their
mixture can be used. Olive oil has been used as a reference substrate
since decades, and it is recommended in most pharmacopeia assays of PL
(see Pancrelipase and pancreatin monographs from European and
United States Pharmacopeia (USP), (United States Pharmacopeia.
(2018), 2018; European Pharmacopoeia, 2019)). Nevertheless, using
long chain TAG as substrate requires the use of emulsifiers such as gum
arabic to form a stable emulsion (Tiss, Carrière, & Verger, 2001).
Moreover, long chain FAs have a pKa close to 7.6 (Benzonana, 1968;
Bakala-N’Goma et al., 2015) and their full titration requires alkaline pH
conditions. The USP pancrelipase assay is thus performed at pH 9, a pH
value that is far different from the physiological conditions of the GI
tract (Bakala N’Goma et al., 2012). Back-titration assays can be per
formed with the release of FAs by the lipase at a physiological pH prior
to FA full titration at pH 9, but these assays are time consuming and not
as precise as the direct titration of FAs (Bakala-N’Goma et al., 2015).
Because of all these drawbacks of long chain FA substrates, the use of a
synthetic short chain oil, such as tributyrin, was introduced in 1970 by
Erlanson and Borgström for the determination of lipase activity of
pancreatic juice and small intestinal content (Erlanson & Borgstrom,
1970). Using tributyrin has several advantages: i) it readily forms a fine
emulsion under mechanical stirring and the addition of emulsifiers is not
necessary; ii) butyric acid (pKa = 4.55) released from tributyrin can be
directly titrated at the physiological pH of the small intestine and even at
acidic pH found in gastric contents using a correction factor (Carrière,
Barrowman, Verger, & Laugier, 1993); iii) the lipolysis products of
tributyrin are soluble in water and do not accumulate at the oil–water
interface like long chain lipolysis products that can subsequently inhibit
lipase activity. Although some researchers were hesitant to use this nonnatural substrate, tributyrin has progressively become a standard sub
strate in many lipase assays, including GL assay, because it allows the

In vitro models simulating gastrointestinal (GI) digestion are widely
used as a tool to study, under well-controlled conditions, a wide range of
food items without the constraints associated with human trials, e.g.
ethics, cost, time, toxicity, limitation in the number of food products that
can be tested or samples that can be collected, issues on variation among
individuals (Hur, Lim, Decker, & McClements, 2011; Guerra et al., 2012;
Minekus et al., 2014; Bornhorst, Gouseti, Wickham, & Bakalis, 2016). In
vitro digestion models are based on the use of digestive enzyme prepa
rations, often from animal sources, as substitutes of salivary, gastric and
pancreatic secretions. Pancreatin from porcine origin is most commonly
used to provide relevant pancreatic enzymes such as proteases, amylase
and lipases (PL), while human salivary α-amylase can be used for pre
paring simulated salivary fluid (Minekus et al., 2014). More recently,
rabbit gastric extract (RGE) has been introduced to provide gastric lipase
(GL) in addition to pepsin in simulated gastric fluid (Brodkorb et al.,
2019). Prior to performing in vitro digestion experiments, it is essential
to assess the activities of these enzyme preparations in order to use
enzyme concentrations that mimic physiological conditions, are
consistent between experiments and enable comparison. With that in
mind, standard protocols have been established based on in vivo data
collected during the digestion of test meals, especially within the
INFOGEST network, an international and multidisciplinary consortium
of researchers from more than 35 countries (http://www.cost-infogest.
eu). Within INFOGEST, a subgroup (WG4) is collaborating and sharing
expertise in the field of lipid digestion phenomena and digestive lipases.
One of its main tasks is to validate and standardize lipase assays for GL
and PL, the two main digestive enzymes involved in triacylglycerols
(TAG) digestion (Bakala N’Goma, Amara, Dridi, Jannin, & Carrière,
2012). Briefly, TAG, are the main dietary lipids (~90%) in the human
diet and GL and PL are the most important enzymes in TAG hydrolysis.
A major difficulty in assaying the activity of these enzymes resides in
the preparation of their substrate that is insoluble in water and forms a
distinct liquid phase dispersed in water. Appropriate substrate emul
sions have to be prepared to allow lipase adsorption and activity at the
oil–water interface. This is essential because most lipases are activated
at this interface by adapting their structure (lid opening) and access to
their catalytic site (Mateos-Diaz et al., 2017). This is the main reason
why many lipase assays with micellar or monomeric substrates rather
than emulsions are not specific or sensitive enough for GL and PL ac
tivity determination. This is the case with most chromogenic and fluo
rogenic substrates that have been developed so far (Beisson, Tiss,
2
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measurement of enzymatic activity at an acidic pH close to the optimum
pH of activity (Gargouri et al., 1986; Carrière et al., 1993). This has
made it possible to use a single reference substrate for both GL and PL
adapted to and optimized for of the reaction conditions for each. GL is
thus assayed in the presence of bile salts (2 mM sodium taurodeox
ycholate (NaTDC)) and bovine serum albumin (BSA, 1.5 µM), whose
roles are to decrease the interfacial tension at the tributyrin-water
interface to avoid interfacial denaturation of the enzyme and thereby
reach optimum conditions of activity (Gargouri, Piéroni, Lowe, Sarda, &
Verger, 1986). PL activity is measured in the presence of a supramicellar
concentration of bile salts (4 mM NaTDC) and of colipase, the specific PL
cofactor that allows lipase anchoring at the oil–water interface in the
presence of bile salts (Borgström, 1975). In both assays, the free fatty
acids (FFAs) released upon tributyrin hydrolysis by the lipase can be
titrated with sodium hydroxide (NaOH) using the pH-stat technique, i.e.
the titration of FFAs at a constant pH value (5.5 for GL and 8 for PL).
Besides lipase assays for the characterization of enzyme prepara
tions, the pH-stat technique has also been used for measuring protein
and lipid digestion in vitro (Beisson et al., 2000; Pinsirodom & Parkin,
2001; Zangenberg, Mullertz, Kristensen, & Hovgaard, 2001; Gilham &
Lehner, 2005; Li & McClements, 2010; Williams et al., 2012; Minekus
et al., 2014; Chatzidaki, Mateos-Diaz, Leal-Calderon, Xenakis, &
Carrière, 2016; Mat, Cattenoz, Souchon, Michon, & Le Feunteun, 2018;
Mat, Souchon, Michon, & Le Feunteun, 2020). One has to be cautious,
however, with the use of the pH-stat technique for these applications for
the reasons previously mentioned (high pKa and poor titration of long
chain FAs without back-titration) and also the strong buffering effects of
some food components that can interfere with the titration.
One of the advantages of implementing the pH-stat technique in a
food digestion laboratory is that it permits the measurement of activities
of other lipolytic enzymes such as pancreatic lipase-related protein 2
(PLRP2), pancreatic carboxyl ester hydrolase (CEH) and pancreatic
phospholipase A2 (sPLA2) using various lipid substrates from which FAs
can be released and titrated (phospholipids, galactolipids, cholesterol
and vitamin esters, synthetic esters) (Fernandez et al., 2008; Fernandez
et al., 2010; Salhi et al., 2020). These assays are however not considered
as part of this work.
The main objectives of this multicentre study were: i) to test the
repeatability and reproducibility of established GL and PL assays using
the pH-stat technique; ii) to identify critical parameters for improving
inter-laboratory variability; iii) to investigate the use of boronic acid as
lipase inhibitor to block lipolysis. For this purpose, 21 laboratory
members of the INFOGEST network involved in the WG4 group received
three sources of lipases (one GL and two PLs) and measured their ac
tivities following the same protocol but using different types of pH-stat
equipment.

2.2. Lipase sources
The 21 laboratories were supplied with three sources of lipases (one
GL and two PLs), each from a single batch. Lyophilized RGE (#RGE25100MG) were a generous gift from Lipolytech S.A. (Marseille, France)
and contained 2.5% w/w of rabbit GL. One source of PL was porcine
pancreatic extract (pancreatin) purchased from Sigma Aldrich (#P7545;
8 × USP specification); this sample is referred to as Sigma pancreatin in
the manuscript. Nordmark Arzneimittel GmbH & Co KG (Uetersen,
Germany) provided the second source of PL, referred to as Nordmark
pancreatin (#N0066397, lipase activity ≥ 80,000 Ph. Eur. U/g). Both
pancreatin sources contained colipase, at a colipase to lipase molar ratio
estimated at around 1.5 (Salhi et al., 2020), in other words a colipase
amount that is sufficient to measure PL activity in the presence of bile
salts without adding exogeneous colipase.
2.3. Enzyme solution preparations
Dispersion of each enzyme powder (1 mg/mL) was prepared by
dissolving 10 mg of enzyme powder in 10 mL of cold ultrapure deionised
water initially stored on ice, vortexed for 30 s and kept on ice until the
assay was performed.
The step-by-step protocol as communicated to the laboratories can
be found in Supplementary Data (see Protocol for preparing enzymes stock
solutions for lipase assays).
It is worth noting that pancreatic extracts are not completely soluble
in water and some enzyme activity (around 10%) remains associated to
insoluble solid particles. We therefore recommended using this enzyme
dispersion without prior filtration of the insoluble material and after
homogenous mixing using a vortex. Also, it was requested to the par
ticipants to perform the assay as soon as possible after preparing the
enzyme solution since RGE and the pancreatin sources contain active
proteases that can rapidly degrade the lipases, especially in pancreatin.
Three different volumes (50, 100 and 200 µL) of each dispersion were
used for the lipase assays, i.e. 50, 100 and 200 µg of enzyme preparation
per assay.
2.4. GL activity assay
The assay solution (pH 5) in which the substrate (tributyrin) emul
sion was formed contained 1.5 µM of BSA, 150 mM of NaCl and 2 mM of
NaTDC, as optimized and described by Moreau et al. (Moreau, Gargouri,
Lecat, Junien, & Verger, 1988) for rabbit GL and by Gargouri et al for
human GL (Gargouri et al., 1986). The step-by-step protocol received by
the laboratories can be found in the Supplementary Data (see Protocol for
the assay of gastric lipase in RGE). The substrate emulsion was prepared
directly in the pH-stat vessel thermostated at 37 ◦ C while mixing 14.5
mL of the assay solution and 0.5 mL of tributyrin. After the temperature
was stabilized, the pH was adjusted to 5.5 and the pH-stat regulation
started to keep this pH value constant. After recording the baseline and
ensuring it was stable over time, the sample to be titrated (50, 100 or
200 µL of the enzyme stock solution, or 100 µL of the enzyme-inhibitor
solution (when GL inhibition is tested; see Section 2.7)) was added and
NaOH (0.1 N) delivery was recorded as a function of time.
Depending on the equipment used (regulation rate) and enzyme
activity, the rate of NaOH delivery may not immediately progress line
arly (presence of a lag time; Fig. 2) and therefore recording of NaOH
delivery was recommended for at least 5 min.
GL activity (AGL) was then estimated from the rate of NaOH delivery.
Since butyric acid is not fully ionized and titrable at pH 5.5, a correction
factor of 1.12 was applied to obtain the full activity from equation (Eq.
(1)):

2. Materials and methods
2.1. Materials and equipment
Trisaminomethane (Tris), sodium chloride (NaCl), calcium chloride
(CaCl2⋅2H2O), NaTDC, NaOH, glyceryl tributyrate (tributyrin, ≥99%;
#T8626 from Sigma-Aldrich), BSA (98%; #A7030 from Sigma-Aldrich),
and 4-bromophenylboronic acid (#B75956 from Sigma-Aldrich) were
purchased by each lab.
Fig. 1 gives a schematic overview of the principle behind the pH-stat
technique and of the different reaction vessel shapes as well as the
stirring devices used by the 21 laboratories. To take part in this study,
the participants were required to have at their disposal a pH-stat device
equipped with a thermostated reaction vessel, a mechanical stirrer
(propeller or magnetic stirrer), an automated system for 0.1 N NaOH
delivery, and a pH electrode adapted for viscous/oily dispersions,
ideally with a sleeve diaphragm.

AGL = (VNaOH /(t2 − t1 )) × N × 1.12

(μmol/min)

(1)

where AGL is the rate of NaOH delivery in µmole per minute or enzyme
3
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Fig. 1. Principle of lipase assay using the pH-stat technique. (A) Triacylglycerol (TAG) is the substrate of lipase (EC3.1.3.1 triacylglycerol hydrolase) that catalyses the
release of free fatty acids (FFAs) from TAG. FFAs can be titrated by NaOH. (B) Schematic illustration of a pH-stat device, equipped with a thermostated reaction
vessel, in which the substrate emulsion is formed by mechanical stirring; a pH-electrode connected to a pH-meter and a control unit for the automated delivery of
NaOH by a burette. Every time the pH decreases due to the release of FFAs, NaOH is delivered to keep the pH constant at a pre-determined endpoint value. The
delivery of NaOH (µmoles) is recorded as a function of time (min) and lipase activity is expressed in µmoles NaOH (or FFAs titrated) per min, with 1 international unit
(U) equal to 1 µmol FFA/min. (C) Different geometries of reaction vessel (conical or cylindrical) and stirring devices (magnetic stirrer or propeller) available at the
laboratories involved in the study.

activity expressed in international units (U) (1 U = 1 µmol of butyric acid
released per minute), VNaOH is the volume of NaOH delivered, in µL,
between times t2 and t1 and N is the titre of NaOH (0.1 N).
In a next step, the specific activity of RGE (SARGE) was calculated
from Eq. (2):
SARGE = (AGL × 1000)/(C × v) (U/mg)

preparations. Since protein amounts in commercial pancreatin prepa
rations are rarely provided, it is more convenient to express specific
activities in IU per mg for researchers performing in vitro digestion
experiments.
For each RGE concentration tested, three repeats were performed
using a fresh preparation for each repeat.

(2)

where SARGE is expressed in U per mg of powder, C is the concentration
(mg/mL) of powder in the enzyme solution and v is the volume of
enzyme solution added in µL.
To note: While biochemists usually express enzyme specific activity
in IU per mg of proteins, it is a common practice to express activities of
pharmaceutical enzyme preparations in IU per mass of material powder
and these activities are the reference for further use of these

2.5. PL activity assay
The assay conditions for the measurement of PL activity were iden
tical to those described in the Supplementary Materials section of the
INFOGEST protocol (Minekus et al., 2014; Brodkorb et al., 2019). They
were based on the original work by Erlanson and Borgström (Erlanson &
Borgstrom, 1970) who introduced the use of tributyrin as substrate for
Fig. 2. Typical titration curves showing the
delivery of NaOH (mL) as a function of time
(min) in the course of a lipase assay with a
pH-stat device. (A) Typical titration curve
with a lag time showing the time period
(around 5 min) during which the volume of
NaOH delivered with time should be
measured. (B) Assay of PL activity with
increasing amounts of pancreatin (50, 100
and 200 µg) showing the proportional in
crease in NaOH delivery rate, as well as the
reduced rate measured in presence of the in
hibitor 4-bromophenyl boronic acid.
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PL and have been established as standard conditions for measuring PL
activity in complex mixtures such as pancreatin (Salhi et al., 2020) or
intestinal contents (Carrière et al., 1993). The assay solution contained
0.3 mM of Tris, 150 mM of NaCl, 2 mM of CaCl2, and 4 mM of NaTDC.
The step-by-step protocol received by the laboratories can be found in
Supplementary Data (see Protocol for the assay of pancreatic lipase in
pancreatin). The substrate emulsion was prepared directly in the pH-stat
vessel thermostated at 37 ◦ C while mixing 14.5 mL of the assay solution
and 0.5 mL of tributyrin. After the temperature was stabilized, the pH
was adjusted to 8 and the pH-stat regulation started to keep this pH
value constant. After recording the baseline and ensuring it was stable
with time, the sample to be titrated (50 µL, 100 µL or 200 µL of the
enzyme stock solution, or 100 µL of the enzyme-inhibitor solution (when
PL inhibition is tested; see Section 2.7)) was added and NaOH (0.1 N)
delivery was recorded as a function of time.
PL activity (APL) was estimated from the rate of NaOH delivery. Since
butyric acid is fully ionized at pH 8, no correction factor was required
and activity was obtained from Eq. (3):
APL = (ΔVNaOH /(t2 − t1 )) × N (μmol/min)

Requirements for Pharmaceuticals for Human Use, 2005). For all tests,
the significance level was set at P < 0.05 (2 tailed). All data are
expressed as means ± SD. Differences between enzyme preparation
concentrations, for a same enzyme source, were analysed by Student’s
paired t-test.
For each enzyme preparation and concentration tested, 63 mea
surements of lipase activity were performed (three replicates for 21
laboratories) and analysed using the Shapiro-Wilk implementation in
XLSTAT. Dixon test for outliers was performed on the average CV values
for each set of 3 replicate measurements. Each laboratory was compared
for the average CV of all replicates. Partial Least Squares (PLS) regres
sion was used to determine the variables (vessel shape, burette volume,
stirring mode, i.e. propeller or magnetic stirrer, and stirring speed) that
have the most significant influence on the lipase activity (Tobias, 1995).
For cross validation, the jackknife (leave-one-out; LOO) was used. The
variables were centred and reduced prior to modelling. The variable
importance for the projection (VIP) scores was determined from the
following equation (5), according to Farrés et al. (Farrés, Platikanov,
Tsakovski, & Tauler, 2015).
√̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅
̅
∑F 2
f =1 wjf ∙SSY f ∙J
(5)
VIPj =
SSY total ∙F

(3)

where APL is the rate of NaOH delivery in µmoles per minute or enzyme
activity expressed in international units (U) per milliliter (1 U = 1 µmol
of butyric acid released per minute), VNaOH is the volume of NaOH
delivered, in µL, between times t2 and t1 and N is the titre of NaOH (0.1
N).
Next, the specific activity of pancreatin (SAPancreatin) was calculated
from Eq. (4):
SApancreatin = (APL × 1000)/(C × v) (U/mg)

where wjf is the weight value for j variable and f component and SSYf is
the sum of squares of explained variance for the fth component and J
number of x variables. SSYtotal is the total sum of squares explained of the
dependent variable and F is the total number of components.

(4)

3. Results

where SAPancreatin is expressed in U per mg of powder, C is the concen
tration (mg/mL) of powder in the enzyme solution and v is the volume of
enzyme solution added in µL.
For each concentration of pancreatin (Sigma or Nordmark) tested,
three repeats were performed using a fresh preparation for each repeat.

3.1. Overview of the equipment used
Instruments from 8 different brands and/or models were used by the
21 laboratories: Titrino (code 1; n = 3) and Titrando (code 2; n = 10)
from Methrom, Mettler Toledo (code 3; n = 2), Radiometer Copenhagen
Meterlab (code 4; n = 1), Kyoto Electronics Manufacturing (code 5; n =
2), Orion (code 6; n = 1), Dasgip Eppendorf (code 7; n = 1) and Cerko
Lab System (code 8; n = 1). Conical reaction vessels (n = 14) were more
widely found than cylindrical vessels (n = 7), and a magnetic stirrer (n
= 14) more than a propeller (n = 7). Diversity was also observed in the
maximum volume (ranging from 25 up to 200 mL) of the reaction vessel
and the maximum volume (5, 10 or 20 mL) of the automated burette
used for NaOH delivery. An automated burette works like a syringe with
a piston. One laboratory (lab 16) used however a Dasgip Eppendorf
bioreactor system instead of a classical pH-stat. This device had no
burette and was based on a different principle (pump) for NaOH
delivery.

2.6. Inhibition of GL and PL by boronic acid
Lipase inhibition was performed by pre-mixing the RGE or the
pancreatin sources with boronic acid. A solution of 4-bromophenylbor
onic acid (1 M) was prepared in methanol (Williams et al., 2012) and 5
µL of this stock solution was added to 1 mL of the enzyme stock solution
at 1 mg powder per mL, prepared as described in Section 2.4. The
mixture was vortexed and incubated at room temperature for 10 min
before performing the assays of residual lipase activity as described in
Sections 2.5 and 2.6.
For the RGE, higher amounts of boronic acid were also tested using
10, 25 and 50 µL of the 1 M stock solution. The assays, for each amount
of boronic acid tested, and the negative control (methanol only) were
performed in triplicate.
To note: Efficient and full inhibition of purified lipases usually re
quires the addition of surfactants like bile salts or lipids because they
favour conformational changes giving inhibitor access to the lipase
active site. However, it is not an absolute requirement with crude
enzyme extracts in which lipases are mixed with other proteins and
residual lipids.

3.2. Specific activities of the lipase preparations
The 21 laboratories involved measured the lipase activities, with
tributyrin as a substrate, of a single batch of RGE as well as a single batch
of each of the two different porcine pancreatin sources from Sigma and
Nordmark, respectively. Assays were performed in triplicate using 3
different amounts of enzyme preparation in each case. Only one labo
ratory (lab 5) deviated from the average CV for all repeated replicates
and was identified as a statistically significant outlier with the Dixon test
having the highest mean CV of 14.2%. The values of this lab were
therefore removed from the mean calculation and the data presented
below. Table 1 shows the average (mean ± SD) of the specific activities
obtained for each amount of enzyme preparation tested. For RGE and
Sigma pancreatin the mean specific activities obtained for the three
amounts tested (50, 100 and 200 µg) did not vary with the amount of
enzyme (Fig. 3), which confirmed that these amounts of lipase were in
the range allowed to measure a constant specific activity. This is a
requirement for enzyme assays indicating that the substrate is in

2.7. Statistical analysis
The data of enzyme activity for the 3 sources of lipases were analysed
using SPSS version 24.0 and the coefficients of variation (CVs) calcu
lated. The International Council for Harmonisation of Technical Re
quirements for Pharmaceuticals for Human Use (ICH) guidelines were
used to define and assess the parameters of precision and evaluate the
magnitude of variation among the activity assessment within and be
tween labs (International Council for Harmonisation of Technical
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2018) and the European Medicines Agency (European Medicines
Agency, 2015), according to which CV values should not exceed 15%.
The inter-laboratory variability was not reduced by removing data from
the outlier laboratory. We therefore searched for the potential sources of
variability among the laboratories involved. Since all laboratories were
provided with the same detailed protocol, including the reagents to be
used, and received lipase samples from the same batches, special
attention was given to the various pH-stat devices that were used and
their respective characteristics (see Table S2 in Supplementary Data).

sufficient excess to fully saturate enzyme active sites. Therefore, specific
activities of GL in RGE and PL in Sigma pancreatin could be averaged
from the three amounts tested and were 22.3 ± 7.1 (n = 63) and 65.9 ±
15.3 (n = 63) U/mg, respectively (Table S1 in Supplementary Data).
These specific activities were slightly lower than those expected from
the suppliers’ information which indicated 25 U/mg for RGE powder
and between 80 and 240 U/mg for Sigma pancreatin (as deduced from
USP units and the equivalence with units determined using tributyrin as
substrate).
For Nordmark pancreatin, the specific activities determined with 50
and 100 µg of the enzyme preparation were both close to 140 U/mg
(Table 1), but the specific activity measured with the third amount
tested, i.e. 200 µg, was 1ower (124.8 ± 34.8 U/mg). This decrease in the
specific activity at the highest concentration tested indicates that this
amount was outside the range allowed for measuring a constant specific
activity. Therefore, only the values obtained with the two lowest con
centrations were considered for estimating the average specific activity
of Nordmark pancreatin (140.9 U/mg, value obtained from data for 50
and 100 µg only). This activity was 2.14-fold higher than the specific
activity of the Sigma pancreatin, as expected from the information
provided by the supplier.
From the measured specific activities and the known specific activ
ities of pure GL and PL (with tributyrin as a substrate), we could estimate
how much active enzymes were present in the preparations (Table 2).
The amount of GL in RGE was found to be 18.3 ± 6.0 µg/mg, while the
amounts of PL in Sigma and Nordmark pancreatin sources were 8.2 ±
1.9 and 17.6 ± 3.7 µg/mg, respectively. We could thus estimate how
much equivalents of pure enzymes were used in the assays when testing
RGE (0.9–3.8 µg GL) and pancreatin sources (0.4 –3.5 µg PL). Since GL
and PL have molecular masses of around 50 kDa and the reaction vol
ume was 15 mL, the enzyme concentrations in the reaction vessel ranged
from 1.2 to 5 nM for GL and from 0.6 to 4.7 nM for PL (Table 2).
The intra-laboratory CVs were overall acceptable with mean values
<10% (Table 1), regardless the enzyme source. On the other hand, the
inter-laboratory variabilities were too large (>21%) to reach interna
tional standards for bioanalytical method validation (see ICH M10
guidelines as well as guidance for bioanalytical methods established by
the Food and Drug Administration (Food and Drug Administration,

3.3. Search for pH-stat devices’ characteristics responsible for the
variabilities observed
All laboratories involved provided characteristics of the pH-stat de
vice they used. Characteristics considered as variables in the following
PLS analysis were: the maximum volume (mL) of the reaction vessel, the
vessel shape (conical or cylindrical), the stirring mode (propeller vs
magnetic stirrer), the stirring speed (rpm) and the maximum burette
volume (mL) for the delivery of NaOH (except for one instrument for
which NaOH delivery was not based on the use of a burette).
PLS regression showed that certain experimental variables resulted
in higher CVs than others (Fig. 4A). It could be seen that only two var
iables had a VIP score larger than 1 (considered statistically significant),
namely the conical and cylindrical shapes of the reaction vessel. Anal
ysis of the contribution of each variable showed either a reduction or an
increase of the CV for a particular laboratory (Fig. 4B). The conical
vessel was associated with the lowest CV, whereas the cylindrical vessel
conversely resulted in the highest CV. This may be attributed to a better
mixing in the conical vessel. This mixing effect is also reflected in the
effect of the volume of the vessel in which the assay was conducted.
Indeed, a positive correlation between vessel volume and CV is shown in
Fig. 4B, i.e. the larger the volume the larger the CV. Interestingly, a
higher stirring speed also resulted in higher CVs, which may be due to
changes in the emulsion droplets size and specific surface accessible for
lipase adsorption and activity. A larger burette volume also resulted in a
larger CV, probably because a larger volume of NaOH is delivered per
actuated motion of the burette piston and regulation of titration is not as
fine as with a smaller burette. The impact of the stirrer type was the least
important. The instrument type was not included in the PLS analysis,
assuming that all relevant instrument parameters were sufficiently
covered by the variables previously mentioned.
Besides the PLS analysis, we also plotted the variations in lipase
specific activities of the three enzyme preparations as a function of the
identified variables. Fig. 5 shows trends for the variables related to
hydrodynamics of the reaction mixture, and thus the formation of the
substrate emulsion. The highest specific activities were measured with
the smallest reaction vessel volume (Fig. 5A) and the highest stirring
rates (Fig. 5C), which is in agreement with the correlations deduced
from the PLS regression. Concerning the vessel shape variables that were
considered as the most influent according to PLS (Fig. 5B), no significant
differences were observed between the mean values for all enzyme
preparations (P < 0.001 for RGE, Sigma and Nordmark pancreatins).
However, the most active enzyme preparation, Nordmark pancreatin,
showed the highest (+8%) specific activity in the conical vessels.
Dispersion of data (SD) around the mean was also reduced with conical
vessels compared to cylindrical vessels and this was observed for all
three enzyme preparations. Concerning the stirring mode, there was a
tendency for measuring higher activities of RGE and Nordmark
pancreatin with a propeller than with a magnetic stirrer (Fig. 5D), which
was not highlighted by the PLS analysis.
Fig. 6 displays the effect of the burette volume, with higher specific
activities measured with the smallest burette volumes, especially for the
Nordmark pancreatin.

Table 1
Specific activities (U/mg of powder) measured with various amounts of each
lipase source with tributyrin as a substrate.
Enzyme source

Amount of
powder tested
(µg)

Specific
activity (U/
mg)*

Mean Intralaboratory CV
%

Interlaboratory CV
%

Lipolytech
RGE

50
100
200
All amounts
50
100
200
All amounts
50

22.3 ± 5.3
22.0 ± 4.7
22.6 ± 10.4
22.3 ± 7.1
66.0 ± 15.7
65.1 ± 17.1
66.5 ± 13.7
65.9 ± 15.3
140.1 ±
30.2
141.7 ±
30.1
124.8 ±
34.8
140.9 ±
29.8

8
5
4
5
8
8
6
6
7

24
21
46
32
24
26
21
23
22

5

21

5

28

5

21

Sigma
pancreatin
Nordmark
pancreatin

100
200
50 + 100

Values are means ± SD (n = 63; in triplicate by 21 laboratories for each amount
tested) and coefficients of variation (CVs in %) were estimated for individual and
for all laboratories involved. For complete data sets, see Tables S1 (data from
individual laboratories with intra-laboratory CV%) and S2 (mean values for each
enzyme preparation and amount for each laboratory, with inter-laboratory CV
%) in Supplementary Data.
*
Constant specific activity in the linear range.
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Fig. 3. Specific activities of the lipases sources as a function of the amount of enzyme preparation used in the assay. (A). Three different amounts (50, 100 and 200 µg) were
tested for each enzyme preparation. (B) Representation of the same specific activities as a function of the pure enzyme equivalents (µg) present in these enzyme
preparations.
Table 2
Estimation of active lipase amounts (µg/mg of powder) in RGE and pancreatins with tributyrin as a substrate.
Enzyme source

Amount of powder tested
(µg)

Specific activity (U/
mg)*

Lipase amounts in the powder (µg/
mg)

Lipase amounts in the assay
(µg)

Lipase concentration in the assay
(nM)

Lipolytech RGE

50
100
200
All amounts
50
100
200
All amounts
50
100
200
50 + 100

22.3 ± 5.4
22.0 ± 4.8
22.6 ± 10.5
22.3 ± 7.1
66.0 ± 15.8
65.1 ± 17.2
66.5 ± 13.8
65.9 ± 15.4
140.1 ± 30.3
141.7 ± 30.2
124.8 ± 34.9
140.9 ± 29.9

18.6 ± 4.5
18.3 ± 4.0
18.8 ± 8.8
18.3 ± 6.0
8.3 ± 2.0
8.1 ± 2.2
8.3 ± 1.7
8.2 ± 1.9
17.5 ± 3.8
17.7 ± 3.8
out of range
17.6 ± 3.7

0.9 ± 0.1
1.8 ± 0.1
3.8 ± 0.2

1.2
2.4
5.0

0.4 ± 0.1
0.8 ± 0.1
1.7 ± 0.1

0.6
1.1
2.2

0.9 ± 0.5
1.8 ± 0.5
3.5 ± 0.5

1.2
2.4
4.7

Sigma pancreatin

Nordmark
pancreatin

This estimation is based on the determination of specific activities (U/mg of powder) measured for each enzyme preparation and the known specific activities of rabbit
GL (1200 U/mg of pure enzyme) (Moreau et al., 1988) and porcine PL (8000 U/mg of pure enzyme) (Tuvignon et al., 2008).
*
Constant specific activity in the linear range.
Fig. 4. Variable importance for the projection
(VIP). (A) Comparison of VIPs influencing
the performance of the test. It can be seen
that only one variable had a VIP larger than 1
(considered statistically significant), namely
the shape of the reactor vessel (conical and
cylindrical). (B) Analysis of the contribution
of each variable showing either a reduction
of the coefficient of variation (CV) for a
particular laboratory (typically vessels with
conical shape) or an increase in the CV for a
particular laboratory (typically vessels with
cylindrical shape).

3.4. Inhibition of lipases by 4-bromophenylboronic acid (series 1, n = 21)

and 6% of residual activity for Sigma and Nordmark pancreatins,
respectively. On the other hand, 34% of gastric lipase from the RGE was
still active when using the same quantity of the inhibitor.
Inhibition assays of gastric lipase were therefore repeated with
higher amounts of boronic acid (10, 25 and 50 µL of a 1 M solution) in a
second series of experiments involving only 8 laboratories out of the 21
(Table 4). This set of laboratories was based on their availability only.

All 21 laboratories were involved in a first series of inhibition assays
performed with 100 µg of each enzyme preparation (after incubation 10
min) with a fixed amount of inhibitor (Table 3). The specific activities of
the two pancreatin sources were significantly reduced (P < 0.0001)
when they were mixed with 4-bromophenylboronic acid, with only 8%
7
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Fig. 5. Impact of pH-stat devices’ charac
teristics on lipase activity measurement.
This Figure illustrates the variations in
lipase specific activities of the three
enzyme preparations (RGE (50, 100 and
200 µg), Sigma pancreatin (50, 100 and
200 µg), and Nordmark pancreatin (50
and 100 µg)) with several characteristic
parameters of the pH-stat devices used in
the various laboratories, namely (A) the
reaction vessel maximum volume, (B)
the vessel shape (conical or cylindrical),
(C) the stirring rate, and (D) the stirrer
type (propeller or magnetic stirrer). Each
dot corresponds to the mean specific
activity (n = 3) measured by one labo
ratory for each amount of enzyme prep
aration. In panels A and C, lines
indicating the trends were obtained by
linear regression.

Addition of 50 µL of inhibitor solution, equivalent to an extremely high
inhibitor to lipase molar ratio of 135,100 resulted in a residual activity
of 12 ± 8%, which was still higher than the residual activities measured
with the two pancreatin sources using a 10-fold lower inhibitor to lipase
molar ratio of 13,500.
3.5. Repetition of GL assay using RGE (series 2, n = 8)
The second series of inhibition assays (n = 8) also repeated the assay
of RGE specific activity using 100 µg of enzyme preparation as controls
without the inhibitors (methanol only). These control assays were per
formed in the presence of a small amount of methanol (5–50 µL), the
solvent used for boronic acid solubilisation, added to the total reaction
volume of 15 mL. The presence of methanol had no effect on the mean
specific activity of RGE (Table 5). Therefore, this second series tested the
repeatability and reproducibility of 100 µg RGE assay on two occasions
for 8 laboratories. The number of repeats per laboratory was, however,
higher in the second series (n = 12) than in the first series (n = 3)
because 3 repeats were performed for each of the four inhibitor amounts
tested. No significant difference was observed between the two series (P
< 0.001). The mean intra-laboratory CV% was increased from 4 (first
series, n = 21) to 10% (second series, n = 8) likely due to a higher
number of repeats performed by each laboratory, but the repeatability
remained acceptable (<15%). Interestingly, the inter-laboratory vari
ability was much improved with a CV% of 10% in the second series
versus 18% in the first series. In addition, this subgroup of 8 laboratories
had already a better reproducibility than the whole group of 21 labo
ratories (CV of 18 vs 21%) in the first series. The possible reasons for this
improvement are analysed in the following discussion section.

Fig. 6. Variations in lipase activities with the maximum volume of the burette for
NaOH delivery. Each dot corresponds to the mean specific activity (n = 3)
measured by one laboratory for each amount of enzyme preparation: 50, 100
and 200 µg for RGE, 50, 100 and 200 µg for Sigma pancreatin, 50 and 100 µg for
Nordmark pancreatin. Lines indicating the trends were obtained by
linear regression.
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Table 3
Residual specific activities of the lipase sources mixed with 4-bromophenylboronic acid.
Enzyme source
Lipolytech RGE
Sigma pancreatin
Nordmark pancreatin

Control
Inhibitor
Control
Inhibitor
Control
Inhibitor

Specific activity (U/mg)*

Coefficient of variation (%)

Residual activity (%)

Inhibitor to lipase molar ratio

22.0 ± 4.7
7.5 ± 0.9
65.1 ± 17.1
5.5 ± 1.0
141.7 ± 30.1
8.9 ± 0.9

21
12
26
19
21
10

34

13,500

8

30,300

6

14,300

Incubations were performed a room temperature for 10 min, after mixing 5 µL of a 4-bromophenylboronic acid solution (1 M) in methanol with 1 mL of the enzyme
stock solution at 1 mg/mL. One hundred µL of this mixture was then used for measuring residual lipase activity. See the Result section for the estimation of the inhibitor
to lipase molar ratio. Specific activity values (U/mg of powder) are means ± SD. The 21 laboratories were involved. See all individual data in Table S1 of Supple
mentary Data.
*
Constant specific activity in the linear range.

correlates with lipase adsorption (Benzonana & Desnuelle, 1965). A
stationary state with a linear release of FFA over time is reached rapidly
after launching the reaction (Fig. 2). Lipase assays with tributyrin are
highly sensitive based on the high specific activities measured with
purified lipases (1200 U/mg for rabbit (Moreau et al., 1988) and human
(Gargouri et al., 1986) GL; 8000 U/mg for human and porcine PL
(Tuvignon et al., 2008)) under optimized assay conditions. These spe
cific activities can also be expressed as molecular turnover number or
catalytic constant (kcat; mole of substrate hydrolysed per mole of enzyme
per unit time), which gives values of 1000 and 6670 s− 1 for GL and PL,
respectively, and places these enzymes in the upper range of all enzyme
activities (Schomburg et al., 2017; Smejkal & Kakumanu, 2019). GL and
PL assays with tributyrin have been used to characterise crude enzyme
preparation (Sternby & Nilsson, 1997; Salhi et al., 2020) and purified
enzymes (Borgström, 1975; Gargouri et al., 1986), as well as to assay
lipase activities in biological samples collected from the GI tract (bi
opsies (Moreau, Laugier, Gargouri, Ferrato, & Verger, 1988), digestive
juices (Erlanson & Borgstrom, 1970; Ville, Carrière, Renou, & Laugier,
2002), gastric and intestinal contents (Erlanson & Borgstrom, 1970;
Carrière et al., 1993)). They have also been used for estimating GL and
PL concentrations in GI tract contents and secretory outputs in the
course of several clinical trials (Sternby, Nilsson, Melin, & Borgström,
1991; Carrière et al., 1993; Borovicka et al., 1997; Carrière et al., 2001;
Renou et al., 2001; Sternby, Hartmann, Borgstrom, & Nilsson, 2002;
Carrière et al., 2005; Roman et al., 2007), because it is possible to
convert enzyme activity (U/mL) into concentration of active enzyme
(mg/mL), knowing the specific activity (U/mg) of pure enzymes. In
some clinical studies, such as S245.2.003 (sponsored by Solvay Phar
maceuticals GmbH), PL assay using tributyrin as substrate has been
validated according to international guidelines for bioanalytical assays
(ICH Guideline Q2A, Validation of Analytical Procedures: Definitions
and Terminology, March 1995 and ICH Guideline Q2B, Validation of
Analytical Procedures: Methodology, May 1997) and approved by the
US Food and Drug Administration (Frédéric Carrière’s personal
communication). The specificity and precision of the PL assays were
therefore considered as acceptable, with definition of lower and upper
limits of quantification.
The use of both GL and PL assays have become more widely spread in
recent years due to their recommendation in the protocols defined by the
INFOGEST network (Minekus et al., 2014; Brodkorb et al., 2019).
Because of this larger use, some discrepancies between laboratories have
appeared, especially when identical batches of enzyme preparation were
tested by different laboratories. It was therefore important to identify
the variables that could explain these differences, although precise
protocols describing the assay conditions had been provided (Minekus
et al., 2014; Brodkorb et al., 2019). In laboratories familiar with pH-stat
assays of lipase activities, it is well known that different results can be
obtained using pH-stat devices from different brands/models. This is
assumed to be caused by differences in reaction vessels (shape and
volume) and stirring modes, because these parameters influence the
formation of the substrate emulsion and thus, the specific surface

Table 4
Residual specific activity (%) of the GL in RGE incubated with various amounts
of 4-bromophenylboronic acid.
Volume of
inhibitor
solution (µL)

Specific
activity (U/
mg)*

Coefficient of
variation (%)

Residual
activity (%)

Inhibitor to
lipase molar
ratio

5

19.5 ± 3.3
8.4 ± 1.9
19.8 ± 3.8
6.3 ± 1.9
19.3 ± 3.1
3.1 ± 1.0
17.9 ± 3.5
2.0 ± 1.1

17
23
19
29
16
30
20
54

44 ± 11

13,500

33 ± 11

27,000

17 ± 7

67,500

12 ± 6

135,100

10
25
50

Control
Inhibitor
Control
Inhibitor
Control
Inhibitor
Control
Inhibitor

A 1 M solution of 4-bromophenylboronic acid was prepared in methanol and 5,
10, 25 or 50 µL of this solution (5, 10, 25 or 50 µmoles) were mixed with 1 mL of
RGE solution at 1 mg powder per mL (containing 18.3 µg or 0.37 nmoles of GL).
Eight laboratories out of 21 were involved in this part of the study. See all in
dividual data in Table S3 of Supplementary Data.
*
Constant specific activity in the linear range.
Table 5
Specific activity of 100 µg RGE (means ± SD) measured in two successive series
by 8 laboratories.
Assay series

Specific activity
(U/mg)

Mean Intra-laboratory
CV(%)

Inter-laboratory CV
(%)

Series 1- All
labs
Series 1–8
labs
Series 2–8
labs

22.0 ± 4.7

5

21

21.6 ± 3.9

4

18

19.1 ± 3.1

10

10

Numbers of assay repeats in each laboratory were n = 3 assays in series 1 and n
= 12 assays in series 2. Coefficient of variations (CVs in %) were estimated for
individual and for all laboratories involved. For complete data sets, see Tables S1
and S3 in Supplementary Data.

4. Discussion
4.1. GL and PL assays using tributyrin as substrate
This study was performed to assess the repeatability and reproduc
ibility of GL and PL assays that are recommended by the INFOGEST
network to characterize lipase preparations prior to in vitro GI digestion
studies. These assays were developed many years ago (Erlanson &
Borgstrom, 1970; Gargouri et al., 1986; Moreau et al., 1988) and are
considered as well optimized regarding reagents of the assay solution,
temperature, pH and substrate. Tributyrin readily forms a fine emulsion
upon mechanical stirring with a high specific surface area ensuring that
all lipase molecules are adsorbed at the lipid-water interface and are
available to form an enzyme-substrate complex. Indeed, lipase activity
9
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available for lipase adsorption and activity at the oil–water interface.
Some laboratories have, for instance, introduced correction factors to
compare results obtained with different types of equipment or by
different collaborators. This is not satisfactory since the result of an
assay should not depend on the equipment utilised to be considered
robust and widely applicable. A water-insoluble substrate, emulsified in
the reaction vessel, can create this dependency and therefore, protocols
should also include recommendations about the parameters of the pHstat equipment to be used. This was the main objective of the ring
trial described in this study and designed by the INFOGEST working
group on lipid digestion and digestive lipases (WG4).

4.3. Optimal pH-stat equipment parameters
This study confirmed that the mixing conditions in the pH-stat vessel
are critical to obtain accurate and reproducible lipase activities. This is
influenced by the shape and size of the reaction vessel, the stirrer type
and the stirring rate (Figs. 1, 4 and 5). Using a reaction vessel with a
conical shape was the most important parameter influencing the interlaboratory variability. In the second series of RGE assays involving
only 8 laboratories out of the 21, most of these laboratories (7 out of 8)
had a pH-stat instrument equipped with a conical vessel (see Table S4 of
Supplementary Data) and reproducibility was improved compared to
the first series of assays (Table 5). The maximum volume of the reaction
vessel had a limited influence (Fig. 5A) but we recommend using a
thermostated conical vessel with a 70 mL maximum capacity, which is a
rather standard model on the market. The stirrer type (propeller vs
magnetic bar) also had only a minor effect, although the highest activity
of the most active enzyme preparation (Nordmark pancreatin) was
recorded with the propeller (Fig. 5D). It is generally recommended to
use a propeller because it allows a better monitoring of the stirring rate
with viscous reaction mixtures. It does not seem to be the case here, but
since the pH-stat equipment can also be used for running in vitro di
gestions of various food systems, we still recommend the propeller as the
best option. Specific activities were found to increase with the stirring
rate (Fig. 5C) as intuitively expected. However, it is worth noting that
the rates provided by the laboratories were often rough estimations of
rates found in the instruction manuals. Indeed, most pH-stat instruments
are equipped with stirrers having a few pre-set rates and it is not possible
to finely adjust the stirring rate. If possible, we would recommend using
a stirring rate between 700 and 800 rpm, a range in which the specific
activities measured with pancreatins are close to the mean specific ac
tivities measured by all laboratories (Fig. 5C). The last variable of
importance was the volume of the burette used for the automated de
livery of NaOH, with higher specific activities recorded with the smallest
burettes (Fig. 6). We assume this is due to the precision of NaOH delivery
to keep the pH of the system at the set value (pH 5.5 for GL and pH 8 for
PL), the smallest burettes being the most precise at adding small vol
umes of NaOH into the reaction vessel. In this ring trial, the smallest
burettes had a volume of 5 mL and we recommend using this volume
although smaller burettes of 2 mL would be even better, as for instance
with the old pH-stat instruments manufactured by Radiometer (TTT80).
Indeed, the latest generation of pH-stat equipment on the market may
not be the most appropriate instruments for measuring lipase activities.
These instruments have been developed for classical acid/base titration
and not enzyme assays during which the rate of acid release varies with
enzyme activity. Ideally, it should be possible to adjust the rate of NaOH
delivery in the course of the titration, which is necessary for systems
having lag times or changes in enzyme activity in the course of the re
actions such as when testing lipase inhibitors.
In conclusion, it is recommended to use a pH-stat device equipped
with a conical vessel of 70 mL maximal capacity, a propeller stirrer
(stirring rate between 700 and 800 rpm) and a burette of 5 mL for NaOH
delivery.

4.2. Choosing the right amount of enzyme preparation for the assay
Another potential source of variability in all enzyme assays are the
respective quantities of enzyme and substrate used per assay. One has to
check that these amounts fall within the range in which the activity is
proportional to the amount of enzyme, i.e. constant specific activity.
This is usually ensured by using a large excess of substrate versus
enzyme to saturate enzyme active sites in the reaction. In this study, we
used enzyme preparations containing micrograms of enzymes, and
lipase concentrations in the assay reaction ranged from around 1 to 5 nM
(Table 2). We used 0.5 mL of tributyrin as a substrate in a 15 mL reaction
volume, which corresponds to an apparent concentration of 113 mM (if
that substrate was not insoluble in water). Substrate to enzyme molar
excess was very large and exceeded 107. Having such a high molar
excess is however not always sufficient to ensure a constant specific
activity of lipases in a large range of enzyme concentrations. Indeed, due
to their peculiar mode of action involving enzyme adsorption at the
lipid-water interface, the adsorption of various amounts of lipase can
change the interfacial properties and thus lipase activity, as would do
any surface active agent (Aloulou et al., 2006; Delorme et al., 2011) or
other proteins present in complex enzyme preparations such as
pancreatin and RGE. This is the reason why a linear relationship be
tween the amount of lipase and lipase activity (or constant specific ac
tivity) is usually observed in a very narrow range of concentrations
when assaying lipases with an emulsified TAG substrate. For instance, a
previous validation of the PL assay has shown that a constant specific
activity could only be measured using 0.5–3.0 µg of pure PL (Frédéric
Carrière’s personal communication).
In the current work, we had preliminary information on lipase con
tents in the pancreatin and RGE, and the laboratories involved in the
ring trial were asked to perform assays with three different quantities of
enzyme preparations (50, 100 or 200 µg) containing suitable amounts of
lipases. This was confirmed by the 21 laboratories involved that ob
tained consistent average specific activities of 22.3 and 65.9 U/mg for
RGE and Sigma pancreatin, respectively, regardless the amount of
enzyme preparation tested (Fig. 3 and Table 1). With Nordmark
pancreatin, a highly active source of pancreatic enzymes used as an
active pharmaceutical ingredient (API) in drug products for the treat
ment of exocrine pancreatic insufficiency, the highest amount tested
(200 µg) contained 3.5 µg of active PL and specific activity decreased
(− 13%) compared to the specific activities estimated with 50 and 100 µg
(Fig. 3). These assays have therefore confirmed the range of enzyme
preparation amounts to be tested and demonstrated that using too much
enzyme in the current assay conditions can result in an underestimation
of the specific activity. This effect might be drastically amplified when
using higher quantities of enzyme. When assaying the lipase activity of a
new or unknown batch of enzyme preparation, we therefore recommend
starting with 50 µg and then double the amount (100 µg) to check if the
activity is doubled while having a constant specific activity. Following
such a procedure will ensure further adaptation of assay conditions in
the future if enzyme manufacturers are providing preparations with
different lipase enrichments.

4.4. The lipase inhibitor 4-bromophenyl boronic acid is not an efficient
inhibitor of GL
Boronic acids were shown to be PL inhibitors by Guarner in 1980
(Garner, 1980). More recently, 4-bromophenyl boronic acid was chosen
as PL inhibitor to stop lipolysis in samples collected from the digestion of
lipid-based formulations (Williams et al., 2012). This blocks lipolysis at
given times during digestion prior to the analysis of lipolysis products
and avoids the evolution of these products into other lipase substrates
like diacyl- and monoacylglycerols. By analogy, it was proposed to use
this inhibitor and a similar protocol to stop lipolysis in samples collected
from food digestion by PL. We confirmed here that 4-bromophenyl
boronic acid significantly inhibits PL present in Sigma and Nordmark
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source has been stored for an extended period of time, to ensure the
targeted activity is reached. The new recommendations presented here
will contribute to a better quality control of enzyme preparations.

pancreatins, with low residual activities of 6–8% after 10 min of incu
bation with an inhibitor to lipase molar ratio of at least 14,300 (Table 3).
For the sake of comparison, a similar inhibition of porcine PL by the
lipase inhibitor Orlistat (also called tetrahydrolipstatin; THL) is ach
ieved using an inhibitor to lipase molar ratio of 10,000 (Gargouri,
Chahinian, Moreau, Ransac, & Verger, 1991). Inhibition of PL by THL
was however shown to be reversible during the assay of residual PL
activity (Tiss, Lengsfeld, Carrière, & Verger, 2009) and therefore 4-bro
mophenyl boronic acid is currently recommended for blocking lipolysis
in samples containing PL.
While THL also acts as an inhibitor of GL, there was no report in the
literature that 4-bromophenyl boronic acid could also inhibit GL. We
therefore tested the inhibition of GL present in RGE using the same
protocol as for PL in pancreatin. An inhibitor to lipase molar ratio of
13,500 was first used, leading to a high residual activity of 34%
(Table 3). Even after increasing the inhibitor to lipase molar ratio up to
135,100, residual GL activity remained high (12 ± 6%; Table 4 and
Fig. 7A). 4-Bromophenyl boronic is therefore a weak inhibitor of GL,
especially compared to THL that fully blocks GL from RGE at an inhib
itor to lipase molar ratio of 2,000 (Fig. 7B) (Gargouri et al., 1991). Halfinhibition of GL is achieved with inhibitor to lipase molar ratio of around
10,000 with 4-bromophenyl boronic compared to approximately 300
with THL.
In conclusion, it is not recommended to use 4-bromophenyl boronic
for GL inhibition but rather THL, an inhibitor very efficient in blocking
gastric lipase and intragastric lipolysis (Carrière et al., 2001).
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